Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net loss	$ (24,797)	$ (117,121)
Amounts to reconcile net loss to net cash flows used in operating activities:
Provision (benefit) for deferred income taxes	(415)	3,781
Depreciation and amortization	56,028	53,315
Amortization of deferred financing costs	2,229	2,209
Loss from unconsolidated joint ventures	2,627	1,609
Stock-based compensation expense	3,786	2,522
Changes in:
Trade receivables	(8,488)	1,823
Accounts payable and accrued liabilities	(17,330)	(4,785)
Other assets and liabilities	(17,814)	13,760
Net cash flows used in operating activities	(4,174)	(42,887)
Cash Flows from Investing Activities:
Purchases of property and equipment	(9,716)	(25,831)
Collection of notes receivable	2,381
Investment in joint ventures	(2,045)	(4,572)
Other investing activities, net	816	5,462
Net cash flows used in investing activities	(8,564)	(24,941)
Cash Flows from Financing Activities:
Net borrowings (repayments) under revolving credit facility		(106,000)
Issuance of senior notes		600,000
Redemption of senior notes		(400,000)
Deferred financing costs paid		(10,540)
Redemption of noncontrolling interest in Operating Partnership		(2,438)
Payment of dividends	(276)	(488)
Payment of tax withholdings for share-based compensation	(3,761)	(3,357)
Other financing activities, net	(66)	(58)
Net cash flows provided by (used in) financing activities	(5,353)	75,869
Net change in cash, cash equivalents, and restricted cash	(18,091)	8,041
Cash, cash equivalents, and restricted cash, beginning of period	163,000	79,754
Cash, cash equivalents, and restricted cash, end of period	144,909	87,795
Term Loan B
Cash Flows from Financing Activities:
Repayments under term loan B	$ (1,250)	$ (1,250)